Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lynch

Showing results (711-720 of 929) with videos related to

Pageof 93
Sort By:
Gynecologic Oncology|September 24, 2004
Analysis of CHEK2 gene for ovarian cancer susceptibilityBora E Baysal, Julie A DeLoia, Joan E Willett-Brozick, et al.
Familial Cancer|May 8, 2004
Cancer variation associated with the position of the mutation in the BRCA2 geneJan Lubinski, Catherine M Phelan, Parviz Ghadirian, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2008
Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncologyJ Stauss, C Franzius, T Pfluger, et al.
Breast Cancer Research and Treatment|April 3, 2015
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancerBradley Downs, Yeong C Kim, Fengxia Xiao, et al.
Journal of the National Cancer Institute|June 3, 1992
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancersA D Thor, I I Moore DH, S M Edgerton, et al.
JAMA Oncology|July 17, 2015
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
Lancet (London, England)|December 10, 1999
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2H Jernström, C Lerman, P Ghadirian, et al.
Neurology|June 1, 1995
Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17R B Petersen, M Tabaton, S G Chen, et al.
BMC Cancer|June 28, 2014
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancerHongxiu Wen, Yeong C Kim, Carrie Snyder, et al.
Pageof 93

Showing results (711-720 of 929) with videos related to

Sort By:
Pageof 93
Gynecologic Oncology|September 24, 2004
Analysis of CHEK2 gene for ovarian cancer susceptibilityBora E Baysal, Julie A DeLoia, Joan E Willett-Brozick, et al.
Familial Cancer|May 8, 2004
Cancer variation associated with the position of the mutation in the BRCA2 geneJan Lubinski, Catherine M Phelan, Parviz Ghadirian, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2008
Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncologyJ Stauss, C Franzius, T Pfluger, et al.
Breast Cancer Research and Treatment|April 3, 2015
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancerBradley Downs, Yeong C Kim, Fengxia Xiao, et al.
Journal of the National Cancer Institute|June 3, 1992
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancersA D Thor, I I Moore DH, S M Edgerton, et al.
JAMA Oncology|July 17, 2015
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
Lancet (London, England)|December 10, 1999
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2H Jernström, C Lerman, P Ghadirian, et al.
Neurology|June 1, 1995
Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17R B Petersen, M Tabaton, S G Chen, et al.
BMC Cancer|June 28, 2014
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancerHongxiu Wen, Yeong C Kim, Carrie Snyder, et al.
Pageof 93